Cytomegalovirus-leukocyte interactions
Hirsch, M.S.
Birth Defects Original Article Series 20(1): 161-173
1984
ISSN/ISBN: 0547-6844 PMID: 6329360 Document Number: 235093
Document emailed within 1 workday
Related Documents
Kaplan, S.S.; Basford, R.E.; Boggs, S.S.; Zdziarski, U.E. 1982: Platelet leukocyte interactions. II. In-vivo correction of Chediak-Higashi leukocyte function with serotonin or normal platelets Advances in Experimental Medicine and Biology 141: 519-530Fan, J.; Meng, X-Qin.; Yang, M-Fang.; Zhou, L.; Chen, X-Ming.; Hu, M-Jun.; Fan, W-Wei.; Ma, W-Hang.; Li, L-Juan. 2006: Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(1): 34-38
Del Principe, D.; Frega, G.; Palumbo, G. 2003: Platelet-leukocyte interactions: platelets possess an antioxidant armamentarium Thrombosis and Haemostasis 90(4): 759-760
Bel'chenko, D.I. 1990: Cellular interactions and changes in the peripheral blood leukocyte composition in hypokinetic rats Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 5: 26-28
Wakefield, A.J.; Hudson, M.; Pounder, R.E. 1995: Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease Advances in Experimental Medicine and Biology 371b: 1307-1311
Woska, J.R.; Morelock, M.M.; Jeanfavre, D.D.; Bormann, B.J. 1996: Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1 Journal of Immunology 156(12): 4680-4685
Howell, J.G.; Zibari, G.B.; Brown, M.F.; Burney, D.L.; Sawaya, D.E.; Olinde, J.G.; Granger, D.N.; McDonald, J.C. 2000: Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions Transplantation 69(2): 300-303
Lipson, S.M.; Falk, L.H.; Lee, S.H. 1996: Effect of leukocyte concentration and inoculum volume on the laboratory identification of cytomegalovirus in peripheral blood by the centrifugation culture-antigen detection methodology Archives of Pathology and Laboratory Medicine 120(1): 53-56
Lombardini, R.; Vaudo, G.; Ciuffetti, G. 1997: Leukocyte-endothelial cell interactions and vascular injury in the earliest preclinical stages of atherosclerosis Haematologica 82(2): 253
Hézard, N.; Metz, D.; Garnotel, R.; Droullé, C.; Potron, G.; Nguyen, P. 2000: Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation Journal des Maladies Vasculaires 25(5): 343-348
Ushiyama, A.; Masuda, H.; Hirota, S.; Ohkubo, C. 2004: Subchronic effects on leukocyte-endothelial interactions in mice by whole body exposure to extremely low frequency electromagnetic fields In Vivo 18(4): 425-432
Del Principe, D.; Frega, G.; Savini, I.; Catani, M.V.; Rossi, A.; Avigliano, L. 2009: The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions Thrombosis and Haemostasis 101(2): 284-289
Keizer, G.D.; Visser, W.; Vliem, M.; Figdor, C.G. 1988: A monoclonal antibody (NKI-L16) directed against a unique epitope on the alpha-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions Journal of Immunology 140(5): 1393-1400
Kloover, J.S.; Soots, A.P.; Krogerus, L.A.; Kauppinen, H.O.; Loginov, R.J.; Holma, K.L.; Bruggeman, C.A.; Ahonen, P.J.; Lautenschlager, I.T. 2000: Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft Transplantation 69(12): 2641-2647
Adler, S.P.; Nigro, G. 2008: The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease Herpes: the Journal of the Ihmf 15(2): 24-27
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065
Coiffier, B.; Souillet, G.; Frobert, Y. 1976: Demonstration of anti-polynuclear leukocyte antibodies in the serum of patients treated with leukocyte concentrates Nouvelle Revue Francaise d'Hematologie 16(1): 151-153
Borkowsky, W.; Lawrence, H.S. 1979: Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay Journal of Immunology 123(4): 1741-1748
Nguyen-fiong-Ohan; Skotnikova, O.I.; Sevast'ianova, M.G.; Borisov, B.N.; Fedorov, N.A. 1980: Human leukemic blood leukocyte DNA contains more breaks than normal leukocyte DNA Biulleten' Eksperimental'noi Biologii i Meditsiny 89(4): 457-459
Goetzl, E.J.; Rocklin, R.E. 1978: Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis Journal of Immunology 121(3): 891-896